Internal Medicine, Pulmonary Disease · Summit, NJ
NPI
1275534323
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1 Springfield Ave, 3rd Floor
Summit, NJ, 07901
Phone (908) 934-0555
Groups this clinician bills Medicare through
Medicare paid, 2024
$208K
3,541 services
Medicare patients, 2024
930
Average age 76
Drug cost, 2024
$2.1M
4,878 prescriptions
Company payments, 2025
$140
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward A Dimitry was code 99214 (office e&m - established), 1,009 times for 616 patients. In total Edward A Dimitry billed 3,541 services in 27 codes, and Medicare paid $208K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,009 | 616 | $104.95 | $106K |
| 94729 Pulmonary Function Testing | Office | 287 | 272 | $7.24 | $2,077 |
| 94010 Pulmonary Function Testing | Office | 280 | 267 | $6.59 | $1,846 |
| 99204 Office E&M - New | Office | 137 | 137 | $140.09 | $19K |
| 99233 Hospital E&M - Subsequent | Facility | 127 | 80 | $98.14 | $12K |
| 94060 Pulmonary Function Testing | Office | 92 | 92 | $8.42 | $775 |
| 99213 Office E&M - Established | Office | 68 | 64 | $67.08 | $4,561 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 61 | 52 | $29.65 | $1,809 |
| 99215 Office E&M - Established | Office | 57 | 55 | $145.92 | $8,317 |
| 99223 Hospital E&M - Initial | Facility | 36 | 36 | $145.50 | $5,238 |
| 99205 Office E&M - New | Office | 31 | 31 | $189.03 | $5,860 |
| 94726 Pulmonary Function Testing | Office | 29 | 29 | $9.94 | $288 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 25 | 24 | $13.98 | $350 |
| 99406 Behavioral Health Services | Office | 19 | 16 | $15.79 | $300 |
By year: 2022 $285K for 4,148 services; 2023 $208K for 3,618 services; 2024 $208K for 3,541 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward A Dimitry prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 544 prescriptions and refills. In total Edward A Dimitry wrote 4,878 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 544 | 748 | 109 | $467K |
| Montelukast Sodium Generic | 528 | 1,513 | 173 | $8,068 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 511 | 658 | 217 | $19K |
| Incruse Ellipta Umeclidinium Bromide | 435 | 535 | 87 | $178K |
| Prednisone Generic | 353 | 497 | 186 | $1,902 |
| Breo Ellipta Fluticasone/Vilanterol | 301 | 462 | 72 | $178K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 237 | 314 | 49 | $143K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 233 | 314 | 64 | $35K |
| Azithromycin Generic | 108 | 115 | 64 | $733 |
| Ventolin Hfa Albuterol Sulfate | 98 | 112 | 30 | $6,269 |
| Advair Hfa Fluticasone Propion/Salmeterol | 97 | 114 | 22 | $35K |
| Spiriva Respimat Tiotropium Bromide | 96 | 144 | 19 | $73K |
| Ipratropium Bromide Generic | 95 | 136 | 43 | $2,653 |
| Spiriva Handihaler Tiotropium Bromide | 89 | 171 | 27 | $83K |
| Doxycycline Hyclate Generic | 82 | 82 | 75 | $838 |
Brand drugs: 2,907 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward A Dimitry $140 ($140 in general payments such as food, travel and fees) from 6 companies. The largest payer was GlaxoSmithKline, LLC. with $34.53.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.